{"EPA_reg_num": "92378-2", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Atmosphere", "Company": "Atmosphere Global LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-09-28", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1029}
{"EPA_reg_num": "1839-166", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "BTC 885 NDC-128", "Company": "Stepan Company", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2020-10-15", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1056}
{"EPA_reg_num": "1839-167", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "BTC 885 Neutral Disinfectant Cleaner-256", "Company": "Stepan Company", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2020-10-08", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1067}
{"EPA_reg_num": "1839-169", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "BTC 885 Neutral Disinfectant Cleaner-64", "Company": "Stepan Company", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2020-10-08", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1068}
{"EPA_reg_num": "1839-168", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "BTC 885 NDC-32", "Company": "Stepan Company", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2020-10-08", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1069}
{"EPA_reg_num": "1839-176", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Liquid-pak Neutral Disinfectant Cleaner", "Company": "Stepan Company", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2020-10-08", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19)", "ID": 1070}
{"EPA_reg_num": "6836-136", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonza Formulation S-18F", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1099}
{"EPA_reg_num": "6836-140", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonza Formulation S-21F", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1100}
{"EPA_reg_num": "6836-77", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonza Formulation S-18", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1102}
{"EPA_reg_num": "6836-381", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonzagard R-82G", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1103}
{"EPA_reg_num": "6836-139", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonza Formulation R-82F", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1104}
{"EPA_reg_num": "6836-346", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonzagard RCS-256", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-27", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1105}
{"EPA_reg_num": "6836-347", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonzagard RCS-128", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-27", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1106}
{"EPA_reg_num": "6836-348", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonzagard RCS-128 PLUS", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-27", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1107}
{"EPA_reg_num": "6836-349", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonzagard RCS-256 Plus", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-27", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1108}
{"EPA_reg_num": "6836-75", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonza Formulation S-21", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1109}
{"EPA_reg_num": "6836-78", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonza Formulation R-82", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1110}
{"EPA_reg_num": "45745-11", "Risk_level": "Safer", "Active_ingredient": "[\"Hydrogen peroxide\"]", "Product_name": "HP2O2", "Company": "Midlab", "Use_site": "[\"Healthcare\", \"Institutional\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\", \"Electrostatic spray\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-07-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1147}
{"EPA_reg_num": "39967-138", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Potassium peroxymonosulfate\", \"Sodium chloride\"]", "Product_name": "Rely+On Virkon", "Company": "Lanxess Corporation", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-09-28", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1170}
{"EPA_reg_num": "1839-100", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Veterinarian Type Disinfectant", "Company": "Stepan Company", "Use_site": "[\"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2020-03-26", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1185}
{"EPA_reg_num": "89833-3", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "D7 Part 1", "Company": "Decon7 Systems LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-20", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1197}
{"EPA_reg_num": "91399-2", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Sodium chlorite\"]", "Product_name": "Biotab7", "Company": "Advanced Biocide Technologies Inc", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact No Rinse (FCNR)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "Feline calicivirus; Norovirus", "Date_on_List_N": "2020-03-26", "Why_on_List_N": "Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1198}
{"EPA_reg_num": "1839-80", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "NP 12.5 Detergent/Disinfectant", "Company": "Stepan Company", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2020-03-26", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19)", "ID": 1205}
{"EPA_reg_num": "1839-97", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "NP 12.5 (D&F) Detergent/Disinfectant", "Company": "Stepan Company", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2020-03-26", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19)", "ID": 1206}
{"EPA_reg_num": "71355-1", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\", \"Glutaraldehyde\"]", "Product_name": "Virocid", "Company": "CID Lines NV", "Use_site": "[\"Institutional\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-10-26", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1270}
{"EPA_reg_num": "1839-96", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "NP 9.0 (D&F) Detergent/disinfectant", "Company": "Stepan Company", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2020-04-23", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1345}
{"EPA_reg_num": "89833-4", "Risk_level": "Safer", "Active_ingredient": "[\"Hydrogen peroxide\"]", "Product_name": "D7 Part 2", "Company": "Decon7 Systems LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-20", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1351}
{"EPA_reg_num": "3573-77", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Sodium hypochlorite\"]", "Product_name": "CSP-3002-3", "Company": "The Proctor & Gamble Company", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "Norovirus; Poliovirus", "Date_on_List_N": "2020-04-16", "Why_on_List_N": "Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1355}
{"EPA_reg_num": "10324-230", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Hydrogen peroxide\", \"Peroxyacetic acid (Peracetic acid)\"]", "Product_name": "Maguard 1522", "Company": "Mason Chemical Company", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "Human coronavirus", "Date_on_List_N": "2020-03-13", "Why_on_List_N": "Kills a human coronavirus similar SARS-CoV-2 (COVID-19)", "ID": 1380}
{"EPA_reg_num": "1839-81", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "NP 9.0 Detergent/disinfectant", "Company": "Stepan Company", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2020-03-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19)", "ID": 1400}
{"EPA_reg_num": "54289-4", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Peroxyacetic acid (Peracetic acid)\"]", "Product_name": "Peraclean 15 (Peroxyacetic Acid Solution)", "Company": "Evonik Corporation", "Use_site": "[\"Healthcare\", \"Institutional\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "Human coronavirus", "Date_on_List_N": "2020-03-13", "Why_on_List_N": "Kills a human coronavirus similar SARS-CoV-2 (COVID-19)", "ID": 1409}
{"EPA_reg_num": "6836-362", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Nugen MB5A-128", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-03-02", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1440}
{"EPA_reg_num": "6836-363", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Nugen MB5A-64", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-03-02", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1441}
{"EPA_reg_num": "6836-366", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Nugen MB5N-64", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-27", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1442}
{"EPA_reg_num": "47371-129", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Formulation HWS- 256", "Company": "H&S Chemicals Division of Arxada LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-05-25", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1459}
{"EPA_reg_num": "47371-130", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Formulation HWS-128", "Company": "H&S Chemicals Division of Arxada LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-05-25", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1460}
{"EPA_reg_num": "47371-131", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "HWS-64", "Company": "H&S Chemicals Division of Arxada LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-05-25", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1461}
{"EPA_reg_num": "47371-192", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Formulation HWS-32", "Company": "H&S Chemicals Division of Arxada LLC", "Use_site": "[\"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-05-25", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1462}
{"EPA_reg_num": "6836-361", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Nugen MB5A-256", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-03-02", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1483}
{"EPA_reg_num": "6836-364", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Nugen MB5N-256", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-27", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1484}
{"EPA_reg_num": "6836-365", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Nugen MB5N-128", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-27", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1485}
{"EPA_reg_num": "70627-58", "Risk_level": "Safer", "Active_ingredient": "[\"Hydrogen peroxide\"]", "Product_name": "Oxy-Team\u2122 Disinfectant Cleaner", "Company": "Diversey Inc", "Use_site": "[\"Healthcare\", \"Institutional\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2020-03-03", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1488}
{"EPA_reg_num": "70627-72", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Sodium hypochlorite\"]", "Product_name": "Avert Sporicidal Disinfectant Cleaner", "Company": "Diversey Inc", "Use_site": "[\"Healthcare\", \"Institutional\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "Canine parvovirus; Norovirus; Hepatitis A virus; Poliovirus Type 1", "Date_on_List_N": "2020-03-03", "Why_on_List_N": "Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1490}
{"EPA_reg_num": "71847-6", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Sodium dichloroisocyanurate\"]", "Product_name": "Klorsept", "Company": "Medentech LTD", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\", \"Electrostatic Spray\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-01-28", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1493}
{"EPA_reg_num": "88494-1", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\", \"Ethanol (Ethyl alcohol)\"]", "Product_name": "Wedge Disinfectant", "Company": "North American Infection Control LTD", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "Human coronavirus", "Date_on_List_N": "2020-03-13", "Why_on_List_N": "Kills a human coronavirus similar SARS-CoV-2 (COVID-19)", "ID": 1530}
{"EPA_reg_num": "98099-1", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Sodium chlorite\"]", "Product_name": "PX10", "Company": "PX10 LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "Feline calicivirus", "Date_on_List_N": "2021-01-07", "Why_on_List_N": "Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1620}
{"EPA_reg_num": "89492-2", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Sodium chlorite\"]", "Product_name": "Dutrion Tablet", "Company": "Dutrion North America Ltd", "Use_site": "[\"Healthcare\", \"Institutional\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "Rotavirus", "Date_on_List_N": "2021-01-28", "Why_on_List_N": "Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1665}
{"EPA_reg_num": "66243-2", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Odo-Ban", "Company": "Clean Control Corp", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "Human coronavirus", "Date_on_List_N": "2021-03-16", "Why_on_List_N": "Kills a human coronavirus similar SARS-CoV-2 (COVID-19)", "ID": 1742}
{"EPA_reg_num": "85837-6", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Hydrogen peroxide\", \"Peroxyacetic acid (Peracetic acid)\"]", "Product_name": "Peraoxy Pro", "Company": "Innovasource LLC", "Use_site": "[\"Healthcare\", \"Institutional\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "Human coronavirus", "Date_on_List_N": "2021-07-13", "Why_on_List_N": "Kills a human coronavirus similar SARS-CoV-2 (COVID-19)", "ID": 2122}
{"EPA_reg_num": "6836-138", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonza Formulation S-38-F", "Company": "Arxada, LLC", "Use_site": "[\"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-11-23", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 2229}
{"EPA_reg_num": "6836-73", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonza Formulation S-38", "Company": "Arxada, LLC", "Use_site": "[\"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-11-23", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19)", "ID": 2230}
{"EPA_reg_num": "70627-84", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Virex Plus", "Company": "Diversey, Inc", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2022-08-31", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 2408}
{"EPA_reg_num": "10324-194", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Maquat 2420-10", "Company": "Mason Chemical Company", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2022-08-31", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19)", "ID": 2409}
{"EPA_reg_num": "63838-36", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "EP-Q7.5", "Company": "Enviro Tech Chemical Services, Inc.", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2022-08-31", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 2412}
{"EPA_reg_num": "5813-135", "Risk_level": "Safer", "Active_ingredient": "[\"Citric acid\"]", "Product_name": "Pyn", "Company": "The Clorox Company", "Use_site": "[\"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2023-08-02", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 2622}